Position in UTHR
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$29,800
-$2,813 QoQ
Shares Held
55
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#756
of 870 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Dunhill Financial, LLC holds $64,818 across 11 Drug Manufacturers - Specialty & Generic names. UTHR ranks #1 (46.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
55 | $29,800 | |
| 2 | ZTS |
Zoetis Inc.
|
353 | $25,366 | |
| 3 | VTRS |
Viatris Inc
|
309 | $4,906 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
12 | $2,022 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
7 | $776 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
50 | $724 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
16 | $554 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
18 | $442 |
All Filings in UTHR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,800 | 55 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $32,613 | 55 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $24,849 | 51 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $20,960 | 50 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $14,367 | 50 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $15,413 | 50 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $35,284 | 100 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,917 | 50 | Shares | Sole | 2024-11-15 | |
| No filing history on record for this holder in this stock. | ||||||